Improving the quality of liver resection: A systematic review and critical analysis of the available prognostic models

HPB

Volumn 17, Issue 3, 2015, Pages 209-221

  Lim, Chetana ^a   Dejong, Cornelius H ^b   Farges, Oliver ^c  

^a HENRI MONDOR HOSPITAL   (France)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c BEAUJON HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; LIVER RESECTION; MORBIDITY; OUTCOME ASSESSMENT; PROGNOSTIC ASSESSMENT; PROSPECTIVE STUDY; QUALITY CONTROL; REVIEW; RISK ASSESSMENT; SURGICAL MORTALITY; SYSTEMATIC REVIEW; ADVERSE EFFECTS; DISEASE FREE SURVIVAL; FEMALE; LIVER NEOPLASMS; MALE; MORTALITY; NEEDS ASSESSMENT; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATIONS; PROCEDURES; PROGNOSIS; SURVIVAL; TOTAL QUALITY MANAGEMENT;

DISEASE-FREE SURVIVAL; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; NEEDS ASSESSMENT; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; QUALITY IMPROVEMENT; RISK ASSESSMENT; SURVIVAL ANALYSIS;

EID: 84922621067     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/hpb.12346     Document Type: Review

References (74)

1. Agrawal S, Belghiti J,. (2011) Oncologic resection for malignant tumours of the liver. Ann Surg 253: 656-665.
2. Dindo D, Muller MK, Weber M, Clavien PA,. (2003) Obesity in general elective surgery. Lancet 361: 2032-2035.
3. Mulligan DC,. (2012) Living donor safety during the performance of hepatectomy. Liver Transpl 18: 1134-1135.
4. Farges O, Vibert E, Cosse C, Pruvot FR, Le Treut YP, Scatton O, et al. (2014) Surgeons' intuition versus prognostic models: predicting the risk of liver resections. Ann Surg 260: 923-930.
5. Asiyanbola B, Chang D, Gleisner AL, Nathan H, Choti MA, Schulick RD, et al. (2008) Operative mortality after hepatic resection: are literature-based rates broadly applicable? J Gastrointest Surg 12: 842-851.
6. Dokmak S, Fteriche FS, Borscheid R, Cauchy F, Farges O, Belghiti J,. (2013) 2012 liver resections in the 21st century: we are far from zero mortality. HPB 15: 908-915.
7. McColl RJ, You X, Ghali WA, Kaplan G, Myers R, Dixon E,. (2008) Recent trends of hepatic resection in Canada: 1995-2004. J Gastrointest Surg 12: 1839-1846.
8. Shah BC, Ullrich F, Smith L, Leiphrakpam P, Ly Q, Sasson A, et al. (2011) National trends in discharge disposition after hepatic resection for malignancy. HPB 13: 96-102.
9. Azoulay D, Castaing D, Krissat J, Smail A, Hargreaves GM, Lemoine A, et al. (2000) Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver. Ann Surg 232: 665-672.
10. Wicherts DA, de Haas RJ, Andreani P, Sotirov D, Salloum C, Castaing D, et al. (2010) Impact of portal vein embolization on longterm survival of patients with primarily unresectable colorectal liver metastases. Br J Surg 97: 240-250.
11. Jaeck D, Oussoultzoglou E, Rosso E, Greget M, Weber JC, Bachellier P,. (2004) A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg 240: 1037-1049.
12. Wicherts DA, Miller R, de Haas RJ, Bitsakou G, Vibert E, Veilhan LA, et al. (2008) Longterm results of two-stage hepatectomy for irresectable colorectal cancer liver metastases. Ann Surg 248: 994-1005.
13. Schnitzbauer AA, Lang SA, Goessmann H, Nadalin S, Baumgart J, Farkas SA, et al. (2012) Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling two-staged extended right hepatic resection in small-for-size settings. Ann Surg 255: 405-414.
14. Folprecht G, Gruenberger T, Bechstein WO, Raab HR, Lordick F, Hartmann JT, et al. (2010) Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomized phase 2 trial. Lancet Oncol 11: 38-47.
15. Dimick JB, Wainess RM, Cowan JA, Upchurch GR Jr, Knol JA, Colletti LM,. (2004) National trends in the use and outcomes of hepatic resection. J Am Coll Surg 199: 31-38.
16. Farges O, Goutte N, Bendersky N, Falissard B,. (2012) Incidence and risks of liver resection: an all-inclusive French nationwide study. Ann Surg 256: 697-704.
17. Knops AM, Legemate DA, Goossens A, Bossuyt PM, Ubbink DT,. (2013) Decision aids for patients facing a surgical treatment decision: a systematic review and meta-analysis. Ann Surg 257: 860-866.
18. Moher D, Liberati A, Tetzlaff J, Altman DG,. (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6: e1000097.
19. Ingui BJ, Rogers MA,. (2001) Searching for clinical prediction rules in MEDLINE. J Am Med Inform Assoc 8: 391-397.
20. Moons KG, Royston P, Vergouwe Y, Grobbee DE, Altman DG,. (2009) Prognosis and prognostic research: what, why, and how? BMJ 338: b375.
21. Hemingway H, Riley RD, Altman DG,. (2009) Ten steps towards improving prognosis research. BMJ 339: b4184.
22. Hayden JA, Cote P, Bombardier C,. (2006) Evaluation of the quality of prognosis studies in systematic reviews. Ann Intern Med 144: 427-437.
23. Andres A, Toso C, Moldovan B, Schiffer E, Rubbia-Brandt L, Terraz S, et al. (2011) Complications of elective liver resections in a centre with low mortality: a simple score to predict morbidity. Arch Surg 146: 1246-1252.
24. Breitenstein S, DeOliveira ML, Raptis DA, Slankamenac K, Kambakamba P, Nerl J, et al. (2010) Novel and simple preoperative score predicting complications after liver resection in non-cirrhotic patients. Ann Surg 252: 726-734.
25. Simons JP, Hill JS, Ng SC, Shah SA, Zhou Z, Whalen GF, et al. (2009) Perioperative mortality for management of hepatic neoplasm: a simple risk score. Ann Surg 250: 929-934.
26. Simons JP, Ng SC, Hill JS, Shah SA, Bodnari A, Zhou Z, et al. (2009) In-hospital mortality for liver resection for metastases: a simple risk score. J Surg Res 156: 21-25.
27. Simons JP, Ng SC, Hill JS, Shah SA, Zhou Z, Tseng JF,. (2010) In-hospital mortality from liver resection for hepatocellular carcinoma: a simple risk score. Cancer 116: 1733-1738.
28. Slankamenac K, Breitenstein S, Held U, Slankamenac K, Kambakamba P, Nerl J, et al. (2009) Development and validation of a prediction score for postoperative acute renal failure following liver resection. Ann Surg 250: 720-728.
29. Bolder U, Brune A, Schmidt S, Tacke J, Jauch KW, Löhlein D,. (1999) Preoperative assessment of mortality risk in hepatic resection by clinical variables: a multivariate analysis. Liver Transpl Surg 5: 227-237.
30. Dimick JB, Cowan JA Jr, Knol JA, Upchurch GR Jr,. (2003) Hepatic resection in the United States: indications, outcomes, and hospital procedural volumes from a nationally representative database. Arch Surg 138: 185-191.
31. Dimick JB, Pronovost PJ, Cowan JA Jr, Lipsett PA,. (2003) Postoperative complication rates after hepatic resection in Maryland hospitals. Arch Surg 138: 41-46.
32. Nguyen GC, Thuluvath NP, Segev DL, Thuluvath PJ,. (2009) Volumes of liver transplant and partial hepatectomy procedures are independently associated with lower postoperative mortality following resection for hepatocellular carcinoma. Liver Transpl 15: 776-781.
33. Paugam-Burtz C, Janny S, Delefosse D, Dahmani S, Dondero F, Mantz J, et al. (2009) Prospective validation of the 'fifty-fifty' criteria as an early and accurate predictor of death after liver resection in intensive care unit patients. Ann Surg 249: 124-128.
34. Wilson R, Crouch EA,. (1987) Risk assessment and comparisons: an introduction. Science 236: 267-270.
35. Leppaniemi A, Clavien PA,. (2013) Reporting complications and outcome: are we there yet? Scand J Surg 102: 219-220.
36. van den Broek MA, van Dam RM, Malago M, Dejong CH, van Brekelen GJ, Olde Damink SW,. (2009) Feasibility of randomized controlled trials in liver surgery using surgery-related mortality or morbidity as endpoint. Br J Surg 96: 1005-1014.
37. Mpabanzi L, van Mierlo KM, Malago M, Dejong CH, Lytras D, Olde Damink SW,. (2013) Surrogate endpoints in liver surgery-related trials: a systematic review of the literature. HPB 15: 327-336.
38. Koch M, Garden OJ, Padbury R, Rahbari NN, Adam R, Capussotti L, et al. (2011) Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery. Surgery 149: 680-688.
39. Rahbari NN, Garden OJ, Padbury R, Brooke-Smith M, Crawford M, Adam R, et al. (2011) Post-hepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery 149: 713-724.
40. Rahbari NN, Garden OJ, Padbury R, Maddern G, Koch M, Hugh TJ, et al. (2011) Post-hepatectomy haemorrhage: a definition and grading by the International Study Group of Liver Surgery (ISGLS). HPB 13: 528-535.
41. Skrzypczyk C, Truant S, Salleron J, Langlois C, Boleslawski E, Koriche D, et al. (2014) Relevance of the ISGLS definition of post-hepatectomy liver failure in early prediction of poor outcome after liver resection: a study on 680 hepatectomies. Ann Surg [Epub ahead of print; PMID: 25243550].
42. Moons KG, Altman DG, Vergouwe Y, Royston P,. (2009) Prognosis and prognostic research: application and impact of prognostic models in clinical practice. BMJ 338: b606.
43. de Haas RJ, Wicherts DA, Andreani P, Pascal G, Saliba F, Ichai P, et al. (2011) Impact of expanding criteria for resectability of colorectal metastases on short- and longterm outcomes after hepatic resection. Ann Surg 253: 1069-1079.
44. Guckelberger O, Thelen A, Benckert C, Schoebel C, Reuter S, Klupp J, et al. (2006) Diabetes mellitus is no independent risk factor for perioperative mortality following hepatic resection. Exp Clin Endocrinol Diabetes 114: 257-261.
45. Taketomi A, Kitagawa D, Itoh S, Harimoto N, Yamashita Y, Gion T, et al. (2007) Trends in morbidity and mortality after hepatic resection for hepatocellular carcinoma: an institute's experience with 625 patients. J Am Coll Surg 204: 580-587.
46. Orri M, Farges O, Clavien PA, Barkun J, Revah-Levy A,. (2014) Being a surgeon-the myth and the reality: a meta-synthesis of surgeons' perspectives about factors affecting their practice and well-being. Ann Surg 260: 721-729.
47. Mayo SC, Shore AD, Nathan H, Edil BH, Hirose K, Anders RA, et al. (2011) Refining the definition of perioperative mortality following hepatectomy using death within 90 days as the standard criterion. HPB 13: 473-482.
48. Reddy SK, Barbas AS, Turley RS, Steel JL, Tsung A, Marsh JW, et al. (2011) A standard definition of major hepatectomy: resection of four or more liver segments. HPB 13: 494-502.
49. Royston P, Moons KG, Altman DG, Vergouwe Y,. (2009) Prognosis and prognostic research: developing a prognostic model. BMJ 338: b604.
50. Altman DG, Vergouwe Y, Royston P, Moons KG,. (2009) Prognosis and prognostic research: validating a prognostic model. BMJ 338: b605.
51. Cauchy F, Zalinski S, Dokmak S, Fuks D, Farges O, Castera L, et al. (2013) Surgical treatment of hepatocellular carcinoma associated with the metabolic syndrome. Br J Surg 100: 113-121.
52. Vonlanthen R, Slankamenac K, Breitenstein S, Puhan MA, Muller MK, Hahnloser D, et al. (2011) The impact of complications on costs of major surgical procedures: a cost analysis of 1200 patients. Ann Surg 254: 907-913.
53. Chok KS, Ng KK, Poon RT, Lo CM, Fan ST,. (2009) Impact of postoperative complications on longterm outcome of curative resection for hepatocellular carcinoma. Br J Surg 96: 81-87.
54. Tanaka K, Kumamoto T, Nojiri K, Matsuyama R, Takeda K, Endo I,. (2010) Impact of postoperative morbidity on longterm survival after resection for colorectal liver metastases. Ann Surg Oncol [Epub ahead of print; doi: 10.1245/s10434-010-1352-1 ].
55. Brown SR, Mathew R, Keding A, Marshall HC, Brown JM, Jayne DG,. (2014) The impact of postoperative complications on longterm quality of life after curative colorectal cancer surgery. Ann Surg 259: 916-923.
56. Beavers KL, Sandler RS, Shrestha R,. (2002) Donor morbidity associated with right lobectomy for living donor liver transplantation to adult recipients: a systematic review. Liver Transpl 8: 110-117.
57. Boleslawski E, Vibert E, Pruvot FR, Le Traut YP, Scatton O, Laurent C, et al. (2014) Relevance of postoperative peak transaminase after elective hepatectomy. Ann Surg 260: 815-821.
58. Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. (2009) The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 250: 187-196.
59. Slankamenac K, Graf R, Barkun J, Puhan MA, Clavien PA,. (2013) The comprehensive complication index: a novel continuous scale to measure surgical morbidity. Ann Surg 258: 1-7.
60. Vollmer CM Jr, Sanchez N, Gondek S, McAuliffe J, Kent TS, Christein JD, et al. (2011) A root-cause analysis of mortality following major pancreatectomy. J Gastrointest Surg 16: 89-102; discussion 102-103.
61. Tsai TC, Joynt KE, Orav EJ, Gawande AA, Jha AK,. (2013) Variation in surgical readmission rates and quality of hospital care. N Engl J Med 369: 1134-1142.
62. Wong-Lun-Hing EM, van Dam RM, Heijnen LA, Busch OR, Terkivatan T, van Hillegersberg R, et al. (2014) Is current perioperative practice in hepatic surgery based on enhanced recovery after surgery (ERAS) principles? World J Surg 38: 1127-1140.
63. Schultz NA, Larsen PN, Klarskov B, Plum LM, Frederiksen HJ, Christensen BM, et al. (2013) Evaluation of a fast-track programme for patients undergoing liver resection. Br J Surg 100: 138-143.
64. Boyd O, Jackson N,. (2005) How is risk defined in high-risk surgical patient management? Crit Care 9: 390-396.
65. Owens WD, Felts JA, Spitznagel EL Jr,. (1978) ASA physical status classifications: a study of consistency of ratings. Anesthesiology 49: 239-243.
66. Makuuchi M, Kosuge T, Takayama T, Yamazaki S, Kakazu T, Miyagawa S, et al. (1993) Surgery for small liver cancers. Semin Surg Oncol 9: 298-304.
67. Yokoyama Y, Nishio H, Ebata T, Igami T, Sugawara G, Nagino M,. (2010) Value of indocyanine green clearance of the future liver remnant in predicting outcome after resection for biliary cancer. Br J Surg 97: 1260-1268.
68. Burden S, Todd C, Hill J, Lal S,. (2012) Preoperative nutrition support in patients undergoing gastrointestinal surgery. Cochrane Database Syst Rev (11): CD008879.
69. Steyerberg EW, Moons KG, van der Windt DA, Hayden JA, Perel P, Schroter S, et al. (2013) Prognosis Research Strategy (PROGRESS) 3: prognostic model research. PLoS Med 10: e1001381.
70. Riley RD, Hayden JA, Steyerberg EW, Moons KG, Abrams K, Kyzas PA, et al. (2013) Prognosis Research Strategy (PROGRESS) 2: prognostic factor research. PLoS Med 10: e1001380.
71. Gabriel SE, Normand SL,. (2012) Getting the methods right-the foundation of patient-centred outcomes research. N Engl J Med 367: 787-790.
72. Walker K, Neuburger J, Groene O, Cromwell DA, van der Meulen J,. (2013) Public reporting of surgeon outcomes: low numbers of procedures lead to false complacency. Lancet 382: 1674-1677.
73. Hemingway H, Croft P, Perel P, Hayden JA, Abrams K, Timmis A, et al. (2013) Prognosis research strategy (PROGRESS) 1: a framework for researching clinical outcomes. BMJ 346: e5595.
74. Blazeby JM, Fayers P, Conroy T, Sezer O, Ramage J, Rees M,. (2009) Validation of the European Organization for Research and Treatment of Cancer QLQ-LMC21 questionnaire for assessment of patient-reported outcomes during treatment of colorectal liver metastases. Br J Surg 96: 291-298.